Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Relationship Between the Gut Microbiome and Systemic Chemotherapy
Samantha M. Ervin, Siddharth Venkat Ramanan, Aadra P. Bhatt
Digestive Diseases and Sciences (2020) Vol. 65, Iss. 3, pp. 874-884
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 12, pp. 725-741
Closed Access | Times Cited: 1009
Influence of Gut Microbiota-Mediated Immune Regulation on Response to Chemotherapy
Yufei Deng, Xiaoying Hou, Haiping Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 604-604
Open Access | Times Cited: 9
Harnessing multi-omics approaches to elucidate the role of Chinese herbal compounds in chemotherapy-induced gastrointestinal damage
Chang Qiao, Haoxiang Zhang, Xiao-Tong Tian, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access | Times Cited: 1
Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy
Bei Yue, Ruiyang Gao, Zhengtao Wang, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 49
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4824-4824
Open Access | Times Cited: 47
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review
Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 38
Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
Taurean Brown, DeLawrence Sykes, Antiño R. Allen
Biomedicines (2021) Vol. 9, Iss. 2, pp. 189-189
Open Access | Times Cited: 33
Antibiotic-induced disruption of the microbiome exacerbates chemotherapy-induced diarrhoea and can be mitigated with autologous faecal microbiota transplantation
Hannah R. Wardill, Stijn A.R. van der Aa, Ana Rita da Silva Ferreira, et al.
European Journal of Cancer (2021) Vol. 153, pp. 27-39
Open Access | Times Cited: 28
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients
Alexander R. Moschen, Yossi Sammy, Zoe Marjenberg, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 7, pp. 861-874
Closed Access | Times Cited: 20
Prebiotics: Ignored player in the fight against cancer
Parichita Mishra, Vidhi Manish Badiyani, Sakshi Jain, et al.
Cancer Reports (2023) Vol. 6, Iss. 11
Open Access | Times Cited: 11
Is There an Interplay between Environmental Factors, Microbiota Imbalance, and Cancer Chemotherapy-Associated Intestinal Mucositis?
Camila Fernandes, Mahara Coelho Crisostomo Miranda, Cássia Rodrigues Roque, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1020-1020
Open Access | Times Cited: 4
Current status and prospect of gut and oral microbiome in pancreatic cancer: Clinical and Translational Perspectives
Pengyu Li, Hanyu Zhang, Menghua Dai
Cancer Letters (2024) Vol. 604, pp. 217274-217274
Closed Access | Times Cited: 4
A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade
Xiaodian Zhang, Hailong Tian, Yang Chen, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Influence of gut microbiota on systemic immune responses and cancer immunotherapy
Swathi P. Murakonda, Sriram Balusu, Haritha Chava, et al.
International review of cell and molecular biology (2025)
Closed Access
Phase IV Metabolism
Deniz Coskuner, Aadra P. Bhatt
Gastroenterology Clinics of North America (2025)
Closed Access
Operationalizing Team Science at the Academic Cancer Center Network to Unveil the Structure and Function of the Gut Microbiome
Kevin McDonnell
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2040-2040
Open Access
Impacts of Vincristine and Prednisolone Chemotherapy on the Canine Gut Microbiota in Dogs Undergoing Treatment for Lymphoma
Juan Antonio Aragón Moreno, Annika Weber, Madison Tipton, et al.
Veterinary and Comparative Oncology (2025)
Open Access
Connecting the dots: Targeting the microbiome in drug toxicity
Yusha Luo, Tingting Zhou
Medicinal Research Reviews (2021) Vol. 42, Iss. 1, pp. 83-111
Closed Access | Times Cited: 20
Composition of the Gut Microbiota Associated with the Response to Immunotherapy in Advanced Cancer Patients: A Chinese Real-World Pilot Study
Xi Cheng, Jiawei Wang, Liu Gong, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5479-5479
Open Access | Times Cited: 14
Oral Supramolecular Adsorbent for Preventing Chemo‐Induced Gastrointestinal Mucositis and Microbial Dysbiosis and for Enhancing Chemoimmunotherapy
Meng Tian, Dongyue Fan, Zhen Liu, et al.
Advanced Materials (2022) Vol. 34, Iss. 50
Closed Access | Times Cited: 14
Impact of the microbiome on colorectal cancer development
Mehul R. Chorawala, Humzah Postwala, Bhupendra G. Prajapati, et al.
Elsevier eBooks (2024), pp. 29-72
Closed Access | Times Cited: 2
Classification of Changes in the Fecal Microbiota Associated with Colonic Adenomatous Polyps Using a Long-Read Sequencing Platform
Po‐Li Wei, Ching-Sheng Hung, Yi‐Wei Kao, et al.
Genes (2020) Vol. 11, Iss. 11, pp. 1374-1374
Open Access | Times Cited: 16
Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine
Graciela Gigola, Pedro Carriere, María Belén Novoa Díaz, et al.
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 10, pp. 1518-1531
Open Access | Times Cited: 13
Metagenomics and chemotherapy‐induced nausea: A roadmap for future research
Sylvia L. Crowder, Aasha I. Hoogland, Taylor Welniak, et al.
Cancer (2021) Vol. 128, Iss. 3, pp. 461-470
Open Access | Times Cited: 11
Clinical efficacy of combination therapy of an immune checkpoint inhibitor with taxane plus platinum versus an immune checkpoint inhibitor with fluorouracil plus platinum in the first-line treatment of patients with locally advanced, metastatic, or recurrent esophageal squamous cell carcinoma
Ying Li, Yanyan Ji, Lin Shen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top